- Home
- ROIV vs MIDD Comparison
ROIV vs MIDD Comparison
Compare ROIV & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- MIDD
- Stock Information
- Founded
- ROIV 2014
- MIDD 1888
- Country
- ROIV United Kingdom
- MIDD United States
- Employees
- ROIV N/A
- MIDD N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- MIDD Industrial Machinery/Components
- Sector
- ROIV Health Care
- MIDD Industrials
- Exchange
- ROIV Nasdaq
- MIDD Nasdaq
- Market Cap
- ROIV 8.4B
- MIDD 7.0B
- IPO Year
- ROIV N/A
- MIDD N/A
- Fundamental
- Price
- ROIV $10.70
- MIDD $149.57
- Analyst Decision
- ROIV Buy
- MIDD Buy
- Analyst Count
- ROIV 4
- MIDD 8
- Target Price
- ROIV $17.50
- MIDD $171.14
- AVG Volume (30 Days)
- ROIV 5.9M
- MIDD 965.5K
- Earning Date
- ROIV 05-29-2025
- MIDD 05-07-2025
- Dividend Yield
- ROIV N/A
- MIDD N/A
- EPS Growth
- ROIV N/A
- MIDD 11.43
- EPS
- ROIV N/A
- MIDD 8.00
- Revenue
- ROIV $122,585,000.00
- MIDD $3,854,863,000.00
- Revenue This Year
- ROIV N/A
- MIDD $5.08
- Revenue Next Year
- ROIV N/A
- MIDD $3.78
- P/E Ratio
- ROIV N/A
- MIDD $18.71
- Revenue Growth
- ROIV 140.04
- MIDD N/A
- 52 Week Low
- ROIV $8.73
- MIDD $118.41
- 52 Week High
- ROIV $13.06
- MIDD $182.73
- Technical
- Relative Strength Index (RSI)
- ROIV 49.07
- MIDD 62.78
- Support Level
- ROIV $10.58
- MIDD $130.90
- Resistance Level
- ROIV $11.77
- MIDD $138.92
- Average True Range (ATR)
- ROIV 0.33
- MIDD 3.88
- MACD
- ROIV -0.07
- MIDD 2.73
- Stochastic Oscillator
- ROIV 13.87
- MIDD 96.99
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About MIDD Middleby Corporation (The)
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.